Kayne Anderson Rudnick Investment Management
EBS icon

Kayne Anderson Rudnick Investment Management’s Emergent Biosolutions EBS Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-70
Closed -$4K – 565
2020
Q1 		$4K Hold
70
– – ﹤0.01% 465
2019
Q4 		$4K Buy
70
+16
+30% +$868 ﹤0.01% 479
2019
Q3 		$3K Hold
54
– – ﹤0.01% 472
2019
Q2 		$3K Buy
+54
New +$2.59K ﹤0.01% 467

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's EBS Position: Q2 2020 in Review

Kayne Anderson Rudnick Investment Management sold out of Emergent Biosolutions (EBS) in Q2 2020, closing a stake of 70 shares — an estimated $4K sold.

Kayne Anderson Rudnick Investment Management first reported a position in EBS in Q2 2019 and held it in 4 quarters. The position peaked at $4K in Q1 2020. 299 funds tracked by Wall St. Rank hold EBS as of Q2 2020.

  • Kayne Anderson Rudnick Investment Management reported no remaining Emergent Biosolutions position as of Q2 2020 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 70 Emergent Biosolutions shares in Q2 2020, an estimated $4K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Emergent Biosolutions in Q2 2019 and held it in 4 quarters.
  • Kayne Anderson Rudnick Investment Management's Emergent Biosolutions position peaked at $4K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2020.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.